source
- Novocure's Optune Mya device denied FDA approval over efficacy concernsNovocure received a "not approvable" letter from the FDA for its Optune Mya system, which was being evaluated for patients with brain metastases from non‑small cell lung cancer after stereotactic r…
- Flu season this year appears to be affecting teens and young adults more severely, experts sayThe article notes that flu activity this year has already resulted in at least 1.7 million reported cases, and health experts are observing that teenagers and young adults are experiencing higher r…